Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 39

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
Historical Cash Flows

The following table summarizes our cash flows for the periods indicated:

  Nine Months Ended      September 30,    (In thousands) 2025  2024  Change Cash flows used in operating activities $(5,609) $(5,783) $174 Cash flows (used in) provided by investing activities  (250)  7,269   (7,519)Cash flows provided by financing activities  5,260   55   5,205 Effect of exchange rate changes on cash  (19)  1   (20)Net change in cash and cash equivalent during period $(618) $1,542  $(2,160)

Cash Flows from Operating Activities

During the nine months ended September 30, 2025, cash used in operating activities was $5.6 million compared to $5.8 million during the nine months ended September 30, 2024. Cash used in operating activities during the nine months ended September 30, 2025, was attributed to a net loss of $8.7 million offset by decreases in operating assets and increases in liabilities of $2.2 million and non-cash stock-based compensation of $0.8 million. Cash used in operating activities during the nine months ended September 30, 2024, was attributed to a net loss of $6.0 million and a non-cash gain of $0.2 million associated with our trading of marketable securities and decreases in operating assets and liabilities of $0.1 million offset by stock-based compensation of $0.6 million.

 29Table of Contents

Cash Flows from Investing Activities

During the nine months ended September 30, 2025, cash provided by investing activities was $0.3 million compared to $7.3 million during the nine months ended September 30, 2024. Cash flows used in financing activities during the nine months ended September 30, 2025, were the result of our investment in Solana. Cash flows provided by investing activities of $7.3 million was the result of $7.8 million received from dispositions of trading marketable securities offset by $0.5 million from purchases of trading marketable securities.

Cash Flows from Financing Activities

During the nine months ended September 30, 2025, cash flows provided by financing activities was $5.3 million compared to $